{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:22:37Z","timestamp":1773220957259,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T00:00:00Z","timestamp":1442880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res Commun"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s11259-015-9645-2","type":"journal-article","created":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T03:23:06Z","timestamp":1442892186000},"page":"217-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization"],"prefix":"10.1007","volume":"39","author":[{"given":"Morteza","family":"Abkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas Sahebghadam","family":"Lotfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jafar","family":"Amani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadijeh","family":"Eskandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi Fasihi","family":"Ramandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jafar","family":"Salimian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza Nikbakht","family":"Brujeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Alamian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Koushki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,22]]},"reference":[{"key":"9645_CR1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/apm.12400","volume":"123","author":"M Abkar","year":"2015","unstructured":"Abkar M, Amani J, Sahebghadam Lotfi A, Nikbakht Brujeni G, Alamian S, Kamali M (2015) Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections. APMIS: Acta Pathol Microbiol Immunol Scand 123:667\u2013675. doi: 10.1111\/apm.12400","journal-title":"APMIS: Acta Pathol. Microbiol. Immunol. Scand."},{"key":"9645_CR2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.vaccine.2006.06.086","volume":"25","author":"M Amidi","year":"2007","unstructured":"Amidi M et al (2007) N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model. Vaccine 25:144\u2013153. doi: 10.1016\/j.vaccine.2006.06.086","journal-title":"Vaccine"},{"key":"9645_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-117-1-25","volume":"117","author":"J Ariza","year":"1992","unstructured":"Ariza J, Gudiol F, Pallares R, Viladrich PF, Rufi G, Corredoira J, Miravitlles MR (1992) Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ann Intern Med 117:25\u201330","journal-title":"Ann Intern Med"},{"key":"9645_CR4","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.vaccine.2011.03.039","volume":"29","author":"SM Bal","year":"2011","unstructured":"Bal SM, Slutter B, Jiskoot W, Bouwstra JA (2011) Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation. Vaccine 29:4025\u20134032. doi: 10.1016\/j.vaccine.2011.03.039","journal-title":"Vaccine"},{"key":"9645_CR5","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1586\/14760584.7.8.1257","volume":"7","author":"U Baumann","year":"2008","unstructured":"Baumann U (2008) Mucosal vaccination against bacterial respiratory infections. Expert Rev Vaccines 7:1257\u20131276","journal-title":"Expert Rev Vaccines"},{"key":"9645_CR6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cellimm.2009.03.002","volume":"257","author":"DM Brown","year":"2009","unstructured":"Brown DM, Kamperschroer C, Dilzer AM, Roberts DM, Swain SL (2009) IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells. Cell Immunol 257:69\u201379. doi: 10.1016\/j.cellimm.2009.03.002","journal-title":"Cell Immunol"},{"key":"9645_CR7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1023\/A:1012128907225","volume":"14","author":"P Calvo","year":"1997","unstructured":"Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ (1997) Chitosan and chitosan\/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res 14:1431\u20131436","journal-title":"Pharm Res"},{"key":"9645_CR8","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","volume":"73","author":"J Cassataro","year":"2005","unstructured":"Cassataro J et al (2005) Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Infect Immun 73:8079\u20138088","journal-title":"Infect Immun"},{"key":"9645_CR9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijpharm.2007.07.035","volume":"349","author":"F Chen","year":"2008","unstructured":"Chen F, Zhang ZR, Yuan F, Qin X, Wang M, Huang Y (2008) In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery. Int J Pharm 349:226\u2013233. doi: 10.1016\/j.ijpharm.2007.07.035","journal-title":"Int J Pharm"},{"key":"9645_CR10","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/IAI.05080-11","volume":"79","author":"B Clapp","year":"2011","unstructured":"Clapp B, Skyberg JA, Yang X, Thornburg T, Walters N, Pascual DW (2011) Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses. Infect Immun 79:4165\u20134174. doi: 10.1128\/IAI.05080-11","journal-title":"Infect Immun"},{"key":"9645_CR11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1286-4579(01)01427-7","volume":"3","author":"A Cloeckaert","year":"2001","unstructured":"Cloeckaert A, Verger JM, Grayon M, Paquet JY, Garin-Bastuji B, Foster G, Godfroid J (2001) Classification of Brucella spp. isolated from marine mammals by DNA polymorphism at the omp2 locus. Microbes Infect 3:729\u2013738","journal-title":"Microbes Infect"},{"key":"9645_CR12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2006.07.046","volume":"25","author":"NJ Commander","year":"2007","unstructured":"Commander NJ, Spencer SA, Wren BW, MacMillan AP (2007) The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes. Vaccine 25:43\u201354. doi: 10.1016\/j.vaccine.2006.07.046","journal-title":"Vaccine"},{"key":"9645_CR13","doi-asserted-by":"crossref","first-page":"21519","DOI":"10.1016\/S0021-9258(20)80572-9","volume":"268","author":"LW Daniel","year":"1993","unstructured":"Daniel LW, Huang C, Strum JC, Smitherman PK, Greene D, Wykle RL (1993) Phospholipase D hydrolysis of choline phosphoglycerides is selective for the alkyl-linked subclass of Madin-Darby canine kidney cells. J Biol Chem 268:21519\u201321526","journal-title":"J Biol Chem"},{"key":"9645_CR14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.vetmic.2008.05.003","volume":"132","author":"MA Fiorentino","year":"2008","unstructured":"Fiorentino MA, Campos E, Cravero S, Arese A, Paolicchi F, Campero C, Rossetti O (2008) Protection levels in vaccinated heifers with experimental vaccines Brucella abortus M1-luc and INTA 2. Vet Microbiol 132:302\u2013311. doi: 10.1016\/j.vetmic.2008.05.003","journal-title":"Vet Microbiol"},{"key":"9645_CR15","first-page":"80","volume":"2","author":"AR Fooks","year":"2000","unstructured":"Fooks AR (2000) Development of oral vaccines for human use. Curr Opin Mol Ther 2:80","journal-title":"Curr Opin Mol Ther"},{"key":"9645_CR16","doi-asserted-by":"crossref","first-page":"e29552","DOI":"10.1371\/journal.pone.0029552","volume":"7","author":"S Fu","year":"2012","unstructured":"Fu S et al (2012) Immunization of mice with recombinant protein CobB or AsnC confers protection against Brucella abortus infection. PLoS One 7:e29552. doi: 10.1371\/journal.pone.0029552","journal-title":"PLoS One"},{"key":"9645_CR17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/187221110791185015","volume":"4","author":"NK Garg","year":"2010","unstructured":"Garg NK, Mangal S, Khambete H, Tyagi RK (2010) Mucosal delivery of vaccines: role of mucoadhesive\/biodegradable polymers. Recent Pat Drug Deliv Formul 4:114\u2013128","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"9645_CR18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9440(10)63097-0","volume":"164","author":"A Gebert","year":"2004","unstructured":"Gebert A, Steinmetz I, Fassbender S, Wendlandt KH (2004) Antigen transport into Peyer\u2019s patches: increased uptake by constant numbers of M cells. Am J Pathol 164:65\u201372. doi: 10.1016\/S0002-9440(10)63097-0","journal-title":"Am J Pathol"},{"key":"9645_CR19","author":"A Ghasemi","year":"2014","unstructured":"Ghasemi A, Jeddi-Tehrani M, Mautner J, Salari MH, Zarnani AH (2014a) Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection. Vaccine. doi: 10.1016\/j.vaccine.2014.09.013","journal-title":"Vaccine"},{"key":"9645_CR20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molimm.2014.06.017","volume":"62","author":"A Ghasemi","year":"2014","unstructured":"Ghasemi A, Zarnani AH, Ghoodjani A, Rezania S, Salari MH, Jeddi-Tehrani M (2014b) Identification of a new immunogenic candidate conferring protection against Brucella melitensis infection in Mice. Mol Immunol 62:142\u2013149. doi: 10.1016\/j.molimm.2014.06.017","journal-title":"Mol Immunol"},{"key":"9645_CR21","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.4049\/jimmunol.173.7.4635","volume":"173","author":"GH Giambartolomei","year":"2004","unstructured":"Giambartolomei GH, Zwerdling A, Cassataro J, Bruno L, Fossati CA, Philipp MT (2004) Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus. J Immunol 173:4635\u20134642","journal-title":"J Immunol"},{"key":"9645_CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molimm.2012.02.126","volume":"51","author":"D Goel","year":"2012","unstructured":"Goel D, Bhatnagar R (2012) Intradermal immunization with outer membrane protein 25 protects Balb\/c mice from virulent B. abortus 544. Mol Immunol 51:159\u2013168. doi: 10.1016\/j.molimm.2012.02.126","journal-title":"Mol Immunol"},{"key":"9645_CR23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.vaccine.2012.12.043","volume":"31","author":"D Goel","year":"2013","unstructured":"Goel D, Rajendran V, Ghosh PC, Bhatnagar R (2013) Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544. Vaccine 31:1231\u20131237. doi: 10.1016\/j.vaccine.2012.12.043","journal-title":"Vaccine"},{"key":"9645_CR24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1286-4579(00)01350-2","volume":"3","author":"B Golding","year":"2001","unstructured":"Golding B et al (2001) Immunity and protection against Brucella abortus. Microbes Infect 3:43\u201348","journal-title":"Microbes Infect"},{"key":"9645_CR25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcimb.2013.00013","volume":"3","author":"AE Gregory","year":"2013","unstructured":"Gregory AE, Titball R, Williamson D (2013) Vaccine delivery using nanoparticles. Front Cell Infect Microbiol 3:13. doi: 10.3389\/fcimb.2013.00013","journal-title":"Front Cell Infect Microbiol"},{"key":"9645_CR26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/17435889.2.6.789","volume":"2","author":"JB Hall","year":"2007","unstructured":"Hall JB, Dobrovolskaia MA, Patri AK, McNeil SE (2007) Characterization of nanoparticles for therapeutics. Nanomedicine (Lond) 2:789\u2013803. doi: 10.2217\/17435889.2.6.789","journal-title":"Nanomedicine (Lond)"},{"key":"9645_CR27","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1517\/17425247.2012.697455","volume":"9","author":"I Jabbal-Gill","year":"2012","unstructured":"Jabbal-Gill I, Watts P, Smith A (2012) Chitosan-based delivery systems for mucosal vaccines. Expert Opin Drug Deliv 9:1051\u20131067. doi: 10.1517\/17425247.2012.697455","journal-title":"Expert Opin Drug Deliv"},{"key":"9645_CR28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2010.05.019","volume":"148","author":"P Johansen","year":"2010","unstructured":"Johansen P, Mohanan D, Martinez-Gomez JM, Kundig TM, Gander B (2010) Lympho-geographical concepts in vaccine delivery. J Control Release 148:56\u201362. doi: 10.1016\/j.jconrel.2010.05.019","journal-title":"J Control Release"},{"key":"9645_CR29","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jconrel.2012.05.040","volume":"161","author":"O Kammona","year":"2012","unstructured":"Kammona O, Kiparissides C (2012) Recent advances in nanocarrier-based mucosal delivery of biomolecules. J Control Release 161:781\u2013794. doi: 10.1016\/j.jconrel.2012.05.040","journal-title":"J Control Release"},{"key":"9645_CR30","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1016\/j.vaccine.2009.05.092","volume":"27","author":"A Kostrzak","year":"2009","unstructured":"Kostrzak A et al (2009) Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells. Vaccine 27:4798\u20134807","journal-title":"Vaccine"},{"key":"9645_CR31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.coi.2013.03.011","volume":"25","author":"P Kumar","year":"2013","unstructured":"Kumar P, Chen K, Kolls JK (2013) Th17 cell based vaccines in mucosal immunity. Curr Opin Immunol 25:373\u2013380. doi: 10.1016\/j.coi.2013.03.011","journal-title":"Curr Opin Immunol"},{"key":"9645_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-1135(02)00241-9","volume":"90","author":"JE Luna-Martinez","year":"2002","unstructured":"Luna-Martinez JE, Mejia-Teran C (2002) Brucellosis in Mexico: current status and trends. Vet Microbiol 90:19\u201330","journal-title":"Vet Microbiol"},{"key":"9645_CR33","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","volume":"74","author":"D Luo","year":"2006","unstructured":"Luo D et al (2006) Protective immunity elicited by a divalent DNA vaccine encoding both the L7\/L12 and Omp16 genes of Brucella abortus in BALB\/c mice. Infect Immun 74:2734\u20132741. doi: 10.1128\/IAI.74.5.2734-2741.2006","journal-title":"Infect Immun"},{"key":"9645_CR34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1477-3155-9-55","volume":"9","author":"A Mahapatro","year":"2011","unstructured":"Mahapatro A, Singh DK (2011) Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnol 9:55. doi: 10.1186\/1477-3155-9-55","journal-title":"J Nanobiotechnol"},{"key":"9645_CR35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/MMBR.59.3.451-480.1995","volume":"59","author":"HL Mobley","year":"1995","unstructured":"Mobley HL, Island MD, Hausinger RP (1995) Molecular biology of microbial ureases. Microbiol Rev 59:451\u2013480","journal-title":"Microbiol Rev"},{"key":"9645_CR36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jconrel.2010.08.012","volume":"147","author":"D Mohanan","year":"2010","unstructured":"Mohanan D et al (2010) Administration routes affect the quality of immune responses: a cross-sectional evaluation of particulate antigen-delivery systems. J Control Release 147:342\u2013349. doi: 10.1016\/j.jconrel.2010.08.012","journal-title":"J Control Release"},{"key":"9645_CR37","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/clind\/16.5.671","volume":"16","author":"JM Montejo","year":"1993","unstructured":"Montejo JM, Alberola I, Glez-Zarate P, Alvarez A, Alonso J, Canovas A, Aguirre C (1993) Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis. Clin Infect Dis 16:671\u2013676","journal-title":"Clin Infect Dis"},{"key":"9645_CR38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2567.2001.01258.x","volume":"103","author":"EA Murphy","year":"2001","unstructured":"Murphy EA, Sathiyaseelan J, Parent MA, Zou B, Baldwin CL (2001) Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL\/6 and susceptible BALB\/c mice. Immunology 103:511\u2013518","journal-title":"Immunology"},{"key":"9645_CR39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","volume":"6","author":"MR Neutra","year":"2006","unstructured":"Neutra MR, Kozlowski PA (2006) Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6:148\u2013158","journal-title":"Nat Rev Immunol"},{"key":"9645_CR40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","volume":"6","author":"G Pappas","year":"2006","unstructured":"Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV (2006) The new global map of human brucellosis. Lancet Infect Dis 6:91\u201399. doi: 10.1016\/S1473-3099(06)70382-6","journal-title":"Lancet Infect Dis"},{"key":"9645_CR41","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","volume":"77","author":"KA Pasquevich","year":"2009","unstructured":"Pasquevich KA et al (2009) Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immun 77:436\u2013445. doi: 10.1128\/IAI.01151-08","journal-title":"Infect Immun"},{"key":"9645_CR42","doi-asserted-by":"crossref","first-page":"e16203","DOI":"10.1371\/journal.pone.0016203","volume":"6","author":"KA Pasquevich","year":"2011","unstructured":"Pasquevich KA et al (2011) An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice. PLoS One 6:e16203","journal-title":"PLoS One"},{"key":"9645_CR43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","volume":"34","author":"SD Perkins","year":"2010","unstructured":"Perkins SD, Smither SJ, Atkins HS (2010) Towards a Brucella vaccine for humans. FEMS Microbiol Rev 34:379\u2013394","journal-title":"FEMS Microbiol Rev"},{"key":"9645_CR44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2008.04.036","volume":"364","author":"Y Perrie","year":"2008","unstructured":"Perrie Y, Mohammed AR, Kirby DJ, McNeil SE, Bramwell VW (2008) Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens. Int J Pharm 364:272\u2013280. doi: 10.1016\/j.ijpharm.2008.04.036","journal-title":"Int J Pharm"},{"key":"9645_CR45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2009.05.012","volume":"31","author":"M Saraiva","year":"2009","unstructured":"Saraiva M, Christensen JR, Veldhoen M, Murphy TL, Murphy KM, O\u2019Garra A (2009) Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 31:209\u2013219. doi: 10.1016\/j.immuni.2009.05.012","journal-title":"Immunity"},{"key":"9645_CR46","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/pgmj.62.734.1077","volume":"62","author":"RA Shakir","year":"1986","unstructured":"Shakir RA (1986) Neurobrucellosis. Postgrad Med J 62:1077\u20131079","journal-title":"Postgrad Med J"},{"key":"9645_CR47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2009.05.011","volume":"138","author":"B Slutter","year":"2009","unstructured":"Slutter B et al (2009) Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. J Control Release 138:113\u2013121. doi: 10.1016\/j.jconrel.2009.05.011","journal-title":"J Control Release"},{"key":"9645_CR48","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.carbpol.2012.04.056","volume":"89","author":"R Subbiah","year":"2012","unstructured":"Subbiah R, Ramalingam P, Ramasundaram S, Kim do Y, Park K, Ramasamy MK, Choi KJ (2012) N,N,N-Trimethyl chitosan nanoparticles for controlled intranasal delivery of HBV surface antigen. Carbohydr Polym 89:1289\u20131297. doi: 10.1016\/j.carbpol.2012.04.056","journal-title":"Carbohydr Polym"},{"key":"9645_CR49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-11-69","volume":"11","author":"K Tabynov","year":"2014","unstructured":"Tabynov K et al (2014a) Influenza viral vectors expressing the Brucella OMP16 or L7\/L12 proteins as vaccines against B. abortus infection. Virol J 11:69. doi: 10.1186\/1743-422X-11-69","journal-title":"Virol J"},{"key":"9645_CR50","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1016\/j.vaccine.2014.08.073","volume":"32","author":"K Tabynov","year":"2014","unstructured":"Tabynov K, Yespembetov B, Sansyzbay A (2014b) Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7\/L12 or Omp16 proteins: evaluation of protection in pregnant heifers. Vaccine 32:5889\u20135892. doi: 10.1016\/j.vaccine.2014.08.073","journal-title":"Vaccine"},{"key":"9645_CR51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/CDLI.7.1.114-118.2000","volume":"7","author":"R Vemulapalli","year":"2000","unstructured":"Vemulapalli R et al (2000) Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus. Clin Diagn Lab Immunol 7:114\u2013118","journal-title":"Clin Diagn Lab Immunol"},{"key":"9645_CR52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2011.07.014","volume":"156","author":"RJ Verheul","year":"2011","unstructured":"Verheul RJ, Slutter B, Bal SM, Bouwstra JA, Jiskoot W, Hennink WE (2011) Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination. J Control Release 156:46\u201352. doi: 10.1016\/j.jconrel.2011.07.014","journal-title":"J Control Release"},{"key":"9645_CR53","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1128\/IAI.00761-12","volume":"80","author":"MA Vitry","year":"2012","unstructured":"Vitry MA et al (2012) Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice. Infect Immun 80:4271\u20134280. doi: 10.1128\/IAI.00761-12","journal-title":"Infect Immun"}],"container-title":["Veterinary Research Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-015-9645-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11259-015-9645-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-015-9645-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T03:21:16Z","timestamp":1653189676000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11259-015-9645-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,22]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["9645"],"URL":"https:\/\/doi.org\/10.1007\/s11259-015-9645-2","relation":{},"ISSN":["0165-7380","1573-7446"],"issn-type":[{"value":"0165-7380","type":"print"},{"value":"1573-7446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,22]]}}}